FORT LEE, N.J., Oct. 15, 2012 /PRNewswire/ -- Herborium Group,
Inc., (HBRM) www.herborium.com, a Botanical Therapeutics®
Company announced today that based on the results of the
3rd Quarter, and estimated performance in the
4th Quarter 2012, as well as rapid growth of sales and
popularity of Kamasutra™ spirit containing the Company's
proprietary herbal formulation, the Company expects estimated
revenues in 2013 to reach 7 figures.
In the 4th Quarter, Herborium will start receiving
revenues from royalties for Kamasutra™ spirit sales that are
already taking place across New
Jersey and commence in New
York before the end of October 2012. In the first
Quarter of 2013, "Lady
Kama" will debut in California. New Jersey, New
York and California
together represent 18% of the total United States sale of liqueur.
Herborium sales of AcnEase®, it's proprietary
all-botanical acne medicine that targets over 120 million acne
sufferers in North America and
Europe, grew by over
21% in the 3rd Quarter of 2012 in comparison to
the same Quarter of 2011. Estimated sales for the
4th Quarter continue to be even more optimistic as sales
in September 2012 were the strongest
ever in the history of the company. AcnEase is being sold in
the US and Canada as well as
through European Union, and recently has also entered Australia and New
Zealand.
"We are very pleased with the sales results of Herborium Team
this year, and with marketing and sales progress of our Kamasutra™
partners. Our focus for the 4th Quarter and for 2013 is
to continue to lay the foundation for a strong recurring revenue
base and profitability," said Dr. Agnes P.
Olszewski, CEO and Chairwomen of Herborium
Group.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to
establish and maintain a differential advantage. The company
sells its products in the US and Europe. For more information, please visit
www.herborium.com and www.acnease.com
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.